Founded in 2000 after the loss of Sandy Rollman, the Sandy Rollman Ovarian Cancer Foundation (SROCF) marks 25 years of advocacy, education and impact. What began as a response to missed warning signs and lack of early detection has grown into a nationally recognized organization, raising more than $6.4 million to fund research, support patients and increase awareness.

A cornerstone of its work is the annual Sandy Sprint 5K Run/Walk, which began in Philadelphia and now extends to Los Angeles and New Jersey. The event funds research grants focused on early detection and improved treatments, while its survivor ceremony offers a powerful reminder that long-term survival is possible.

In 2026, an estimated 20,890 women will be diagnosed and 12,730 will die from ovarian cancer, the most deadly gynecologic cancer and the fifth-leading cause of cancer death among women in the U.S. SROCF continues to encourage women to learn the symptoms and prioritize their health year-round.

Executive Director and Co-Founder Robin Cohen shares, “Every woman deserves a fighting chance.”

For more information, visit www.SandyOvarian.org.